Publication — IRIC

Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.

Distinguishing lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has a tremendous therapeutic implication. Sometimes, the commonly used immunohistochemistry (IHC) markers fail to discriminate between them, urging for the identification of new diagnostic biomarkers.

Date de publication
1er août 2018
El-Khoury V, Béland M, Schritz A, Kim SY, Nazarov PV, Gaboury L, Sertamo K, Bernardin F, Batutu R, Antunes L, Bennett CW, Faÿs F, Berchem G, Kim YJ
Référence PubMed
Br. J. Cancer 2018;119(5):580-590
ID PubMed
Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, 1 A-B Rue Thomas Edison, L-1445, Strassen, Luxembourg.